Synovus Financial’s NEVRO CORP. NVRO Stock Holding History

Synovus Financial’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-504	Closed	-$50K	–	2178
2020 Q1	$50K	Buy	+504	New	+$60.6K	﹤0.01%	1117

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Synovus Financial's NVRO Position: Q2 2020 in Review

Synovus Financial sold out of NEVRO CORP. (NVRO) in Q2 2020, closing a stake of 504 shares — an estimated $50K sold.

Synovus Financial first reported a position in NVRO in Q1 2020 and held it in 1 quarter. The position peaked at $50K in Q1 2020. 202 funds tracked by Wall St. Rank hold NVRO as of Q2 2020.

Synovus Financial reported no remaining NEVRO CORP. position as of Q2 2020 after selling out during the quarter.
Synovus Financial sold 504 NEVRO CORP. shares in Q2 2020, an estimated $50K.
Synovus Financial first reported a position in NEVRO CORP. in Q1 2020 and held it in 1 quarter.
Synovus Financial's NEVRO CORP. position peaked at $50K in Q1 2020.
202 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.